LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 194 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $525,918 | -54.6% | 8,777 | -45.4% | 0.00% | -100.0% |
| Q2 2023 | $1,158,791 | +27.1% | 16,072 | +29.7% | 0.00% | 0.0% |
| Q1 2023 | $911,850 | +5.3% | 12,396 | -4.4% | 0.00% | 0.0% |
| Q4 2022 | $866,262 | -76.3% | 12,968 | -69.4% | 0.00% | -66.7% |
| Q3 2022 | $3,648,000 | +11.6% | 42,362 | +15.6% | 0.00% | +50.0% |
| Q2 2022 | $3,269,000 | +21.4% | 36,639 | +53.1% | 0.00% | 0.0% |
| Q1 2022 | $2,693,000 | -58.6% | 23,938 | -43.2% | 0.00% | -33.3% |
| Q4 2021 | $6,508,000 | +30.7% | 42,136 | +17.9% | 0.00% | 0.0% |
| Q3 2021 | $4,978,000 | +7.9% | 35,731 | +1.6% | 0.00% | 0.0% |
| Q2 2021 | $4,615,000 | +4.8% | 35,174 | +21.7% | 0.00% | 0.0% |
| Q1 2021 | $4,405,000 | +82.4% | 28,896 | +19.0% | 0.00% | +200.0% |
| Q4 2020 | $2,415,000 | +127.2% | 24,280 | +117.6% | 0.00% | – |
| Q3 2020 | $1,063,000 | -73.8% | 11,156 | -69.3% | 0.00% | -100.0% |
| Q2 2020 | $4,064,000 | +36.1% | 36,346 | -11.5% | 0.00% | 0.0% |
| Q1 2020 | $2,987,000 | -51.5% | 41,065 | -30.4% | 0.00% | -25.0% |
| Q4 2019 | $6,154,000 | +26.1% | 59,007 | +20.4% | 0.00% | +33.3% |
| Q3 2019 | $4,880,000 | +61.4% | 49,026 | +85.2% | 0.00% | +50.0% |
| Q2 2019 | $3,023,000 | -46.6% | 26,473 | -41.2% | 0.00% | -60.0% |
| Q1 2019 | $5,658,000 | -44.2% | 45,013 | -39.8% | 0.01% | -50.0% |
| Q4 2018 | $10,146,000 | +10.7% | 74,765 | +123.9% | 0.01% | +42.9% |
| Q3 2018 | $9,167,000 | +238.3% | 33,393 | +155.2% | 0.01% | +250.0% |
| Q2 2018 | $2,710,000 | -61.5% | 13,083 | -69.3% | 0.00% | -71.4% |
| Q1 2018 | $7,045,000 | +12.2% | 42,653 | -7.0% | 0.01% | +40.0% |
| Q4 2017 | $6,278,000 | +15.4% | 45,847 | +14.7% | 0.01% | +25.0% |
| Q3 2017 | $5,442,000 | -27.7% | 39,962 | -35.5% | 0.00% | -42.9% |
| Q2 2017 | $7,523,000 | +115.7% | 61,975 | +88.0% | 0.01% | +133.3% |
| Q1 2017 | $3,488,000 | -68.5% | 32,958 | -69.8% | 0.00% | -70.0% |
| Q4 2016 | $11,076,000 | +475.1% | 109,011 | +477.8% | 0.01% | +900.0% |
| Q3 2016 | $1,926,000 | +167.9% | 18,868 | +213.0% | 0.00% | 0.0% |
| Q2 2016 | $719,000 | -48.4% | 6,028 | -53.7% | 0.00% | -50.0% |
| Q1 2016 | $1,394,000 | -67.1% | 13,020 | -66.7% | 0.00% | -50.0% |
| Q4 2015 | $4,239,000 | +32.3% | 39,092 | +4.5% | 0.00% | +33.3% |
| Q3 2015 | $3,203,000 | +2308.3% | 37,400 | +2737.6% | 0.00% | – |
| Q2 2015 | $133,000 | -2.2% | 1,318 | -25.2% | 0.00% | – |
| Q1 2015 | $136,000 | -80.0% | 1,761 | -86.2% | 0.00% | -100.0% |
| Q4 2014 | $681,000 | +45.5% | 12,792 | +28.5% | 0.00% | – |
| Q3 2014 | $468,000 | +735.7% | 9,953 | +1001.0% | 0.00% | – |
| Q2 2014 | $56,000 | -30.0% | 904 | -24.1% | 0.00% | – |
| Q1 2014 | $80,000 | -77.5% | 1,191 | -82.3% | 0.00% | – |
| Q4 2013 | $355,000 | +102.9% | 6,736 | +66.4% | 0.00% | – |
| Q3 2013 | $175,000 | +2400.0% | 4,049 | +2137.0% | 0.00% | – |
| Q2 2013 | $7,000 | – | 181 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $12,937,000 | 4.12% |
| Stonepine Capital Management, LLC | 73,700 | $8,291,000 | 3.44% |
| VILLERE ST DENIS J & CO LLC | 510,843 | $57,464,000 | 3.41% |
| Chicago Capital, LLC | 491,717 | $55,313,000 | 2.38% |
| Orchard Capital Management, LLC | 73,596 | $8,279,000 | 2.35% |
| RICE HALL JAMES & ASSOCIATES, LLC | 344,969 | $38,806,000 | 1.55% |
| Smith, Graham & Co., Investment Advisors, LP | 86,834 | $9,768,000 | 1.02% |
| WOODSTOCK CORP | 64,050 | $7,205,000 | 0.84% |
| INVESTMENT MANAGEMENT OF VIRGINIA LLC | 37,246 | $4,190,000 | 0.74% |
| Stephens Investment Management Group LLC | 417,670 | $46,984,000 | 0.69% |